Week (month) |
0 |
1 (1) |
4 (1) |
8 (2) |
12 (3) |
24 (6) |
Treatment Period (12 weeks) |
|
X |
X |
X |
X |
|
Device dispensation |
X |
|
|
|
|
|
e-liquid dispensation |
X |
|
X |
X |
|
|
1 week check in |
|
X |
|
|
|
|
Measures: Primary Objectives |
|
|
|
|
|
|
Familiarity with vaporized nicotine products (VNPs)—survey |
X |
|
|
|
|
|
Attitudes and use of VNPs—survey |
X |
|
X |
X |
X |
X |
Attitudes towards smoking, quitting and VNPs—interview |
X |
|
|
|
X |
|
Measures: Secondary Objectives |
|
|
|
|
|
|
Cigarettes per day (CPD) |
X |
|
X |
X |
X |
X |
Quit attempts |
X |
|
X |
X |
X |
X |
Abstinence measures |
|
|
X |
X |
X |
X |
Demographics |
X |
|
|
|
|
|
Smoking and quitting |
X |
|
|
|
|
|
Knowledge of harms |
X |
|
|
|
X |
|
Quitting self-efficacy |
X |
|
|
|
X |
|
Fagerstrom Test for Nicotine Dependence (FTND) |
X |
|
|
|
X |
|
Glover Nilsson Smoking Behavioural Questionnaire (GNSBQ) |
X |
|
|
|
X |
|
Adverse events |
|
X |
X |
X |
X |
X |